SCHEMBL6949944

SCHEMBL6949944

[CH2]CC(Cc1ccccc1)C1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
EPHX2 P34913 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
EPHX1 P07099 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MME P08473 2/20 0.37
ACE P12821 2/20 0.37
CPA1 P15085 2/20 0.37
ACE2 Q9BYF1 2/20 0.37
GRIN2B Q13224 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
POLB P06746 1/20 0.36
IDO1 P14902 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9346838 0.84 EPHX1 (0.43) SIGMAR1EPHX1MMEACECPA1
SCHEMBL16191154 0.80 TDP1 (0.43) TDP1EPHX2SIGMAR1
SCHEMBL522762 0.80 ALDH1A1 (0.47) TDP1EPHX2SIGMAR1EPHX1ALDH1A1
SCHEMBL7368102 0.80 EPHX1 (0.46) TDP1SIGMAR1EPHX1SLC6A2SLC6A4
SCHEMBL7492155 0.78 TRPA1 (0.44) TDP1HPGDALDH1A1MMEACE
SCHEMBL7496228 0.78 TRPA1 (0.44) TDP1HPGDALDH1A1MMEACE
SCHEMBL31117977 0.78 EPHX1 (0.42) SIGMAR1EPHX1ALDH1A1SLC6A2SLC6A4
SCHEMBL6031710 0.77 EPHX1 (0.40) TDP1SMN1; SMN2HPGDEPHX2EPHX1
SCHEMBL11868464 0.76 EPHX1 (0.43) TDP1EPHX2SIGMAR1EPHX1MME
SCHEMBL28897690 0.76 SIGMAR1 (0.43) TDP1EPHX2SIGMAR1MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268433-A1 CYCLIC LACTAMS AS INHIBITORS OF A-BETA-PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-01-02 EP disclosed
WO-2001074783-A1 CYCLIC LACTAMS AS INHIBITORS OF A ΒΕΤΑ PROTEIN PRODUCTION DUPONT PHARMACEUTICALS COMPANY (US) 2001-10-11 WO disclosed